clorazepate dipotassium has been researched along with buprenorphine in 6 studies
Studies (clorazepate dipotassium) | Trials (clorazepate dipotassium) | Recent Studies (post-2010) (clorazepate dipotassium) | Studies (buprenorphine) | Trials (buprenorphine) | Recent Studies (post-2010) (buprenorphine) |
---|---|---|---|---|---|
325 | 90 | 11 | 7,273 | 1,223 | 3,826 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (16.67) | 18.2507 |
2000's | 4 (66.67) | 29.6817 |
2010's | 1 (16.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Daubländer, M; Lipp, M | 1 |
Barré, L; Coquerel, A; Debruyne, D; Lelong-Boulouard, V; Poisnel, G; Quentin, T | 2 |
Boulouard, M; Coquerel, A; Debruyne, D; Lelong-Boulouard, V; Moreaux, F; Quentin, T | 1 |
Dervaux, A; Kanit, M; Laqueille, X; Launay, C | 1 |
Bourgine, J; Coquerel, A; Freret, T; Lange, M; Lelong-Boulouard, V; Ma, LL | 1 |
1 review(s) available for clorazepate dipotassium and buprenorphine
Article | Year |
---|---|
[Abuse of alcohol and benzodiazepine during substitution therapy in heroin addicts: a review of the literature].
Topics: Adolescent; Adult; Alcoholism; Benzodiazepines; Buprenorphine; Clonazepam; Clorazepate Dipotassium; Comorbidity; Controlled Clinical Trials as Topic; Diazepam; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Combination; Ethanol; Euphoria; Flunitrazepam; Heroin Dependence; Humans; Metabolic Clearance Rate; Methadone; Narcotics; Substance-Related Disorders; Young Adult | 2009 |
5 other study(ies) available for clorazepate dipotassium and buprenorphine
Article | Year |
---|---|
[Premedication and analgesic dose procedures in dental medicine].
Topics: Anesthesia, Dental; Anesthesia, Local; Buprenorphine; Clorazepate Dipotassium; Diazepam; Flunitrazepam; Humans; Lorazepam; Meperidine; Midazolam; Morphine; Oxazepam; Pain; Pentazocine; Pirinitramide; Preanesthetic Medication | 1991 |
Acute and chronic administration of clorazepate modifies the cell surface regulation of mu opioid receptors induced by buprenorphine in specific regions of the rat brain.
Topics: Animals; Binding Sites; Brain; Buprenorphine; Clorazepate Dipotassium; Drug Administration Schedule; Drug Interactions; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; GABA Modulators; Male; Narcotics; Neurons; Rats; Rats, Sprague-Dawley; Receptors, Opioid, mu; Tissue Distribution; Tritium | 2005 |
Clorazepate affects cell surface regulation of delta and kappa opioid receptors, thereby altering buprenorphine-induced adaptation in the rat brain.
Topics: Adaptation, Physiological; Animals; Anti-Anxiety Agents; Brain; Buprenorphine; Clorazepate Dipotassium; Drug Interactions; Male; Narcotic Antagonists; Rats; Rats, Wistar; Receptors, Opioid, delta; Receptors, Opioid, kappa; Tissue Distribution | 2005 |
Interactions of buprenorphine and dipotassium clorazepate on anxiety and memory functions in the mouse.
Topics: Animals; Anti-Anxiety Agents; Arousal; Avoidance Learning; Buprenorphine; Clorazepate Dipotassium; Dose-Response Relationship, Drug; Drug Synergism; Fear; Male; Maze Learning; Memory, Short-Term; Mental Recall; Mice; Mice, Inbred Strains; Motor Activity; Narcotics; Receptors, Opioid, mu; Reinforcement, Psychology; Retention, Psychology | 2006 |
Benzodiazepines increase the reward effects of buprenorphine in a conditioned place preference test in the mouse.
Topics: Amphetamine; Animals; Bromazepam; Buprenorphine; Clorazepate Dipotassium; Conditioning, Psychological; Diazepam; Dose-Response Relationship, Drug; Drug Interactions; Male; Mice; Reward | 2014 |